Takara Holdings had a results announcement scheduled for August 7. It never happened. The Kyoto-based biotech and beverage group told the Tokyo Stock Exchange on August 12 that disclosure of its first-quarter results for the year ending March 2027 will now run past the standard 45-day window after quarter-end, and that a new date has not been set.
The trigger came from the company's own auditor, not from Takara Holdings itself. At 11:40pm on August 6, the night before the scheduled announcement, the auditor gave first notice that questions had arisen over the accounting treatment at Takara Bio USA, Inc., a consolidated subsidiary. Less than eight hours later, at 7:58am on August 7, the auditor went further: it told the company it could not express a conclusion in its interim review of the quarterly consolidated financial statements until the facts, including whether there is any financial impact, become clear. Takara Holdings pulled the announcement that same day and opened an investigation.
That investigation now involves outside lawyers and certified public accountants working alongside the company to establish what happened at the US unit. Takara Holdings has not disclosed what the accounting questions concern, only that establishing the facts is its immediate priority and that it needs more time to do so.
The subsidiary in question
Takara Bio USA is based in San Jose, California, and run by President and CEO Andrew Farmer. It is a modest piece of the group by capital, listed at $83,000, but it employs 244 people as of the year ended March 2026. Its revenue has declined for three straight years on the figures the company disclosed alongside the delay notice.
| Calendar year | Revenue (thousand USD) |
|---|---|
| 2023 | 120,786 |
| 2024 | 113,029 |
| 2025 | 107,217 |
That three-year slide predates the current accounting question and is not, on the evidence disclosed, linked to it. But it gives the subsidiary's finances a backdrop against which any accounting issue will be read once the facts emerge.
What is unresolved
Takara Holdings has apologized to shareholders and investors for the disruption and says it will announce a new earnings date as soon as one is set. Until the fact-finding is complete, neither the nature of the accounting question nor its financial impact, if any, has been disclosed. The auditor's position is narrower than a refusal to certify annual accounts: it has said it cannot complete the interim review procedure for the quarterly consolidated statements until the facts are clarified, which is why the release itself, not just the underlying numbers, is on hold.